ERYTECH annuncia la presentazione di un poster per TRYbeCA1 in occasione di ASCO 2020

    NEXT STORY
    Roche submits supplemental Biologics License Application to the FDA for Tecentriq in combination with Avastin for the most common form of liver cancer
    PREV STORY
    The fluoroscopy equipment market is projected to reach USD 7.11 billion by 2024 from USD 5.75 billion in 2019, at a CAGR of 4.4%
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Zai Lab Completes Enrollment of China Pivotal Trial of Niraparib as Second-Line Maintenance Therapy for Ovarian Cancer in China

    SHANGHAI, China, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a ...

    author_avatar
    NASDAQ Market News

    VBI Vaccines to Participate in the 2018 Oppenheimer Boston Oncology Insight Summit

    CAMBRIDGE, Mass., July 09, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”), a ...

    author_avatar
    NASDAQ Market News

    Aquinox Prices Public Offering of Common Stock

    VANCOUVER, British Columbia, Sept. 19, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), ...

    author_avatar
    NASDAQ Market News